Author:
Xu Wenqian,Li Haiyi,Zhao Peizhen,Wang Jinshen,Liang Peng,Wang Cheng
Funder
The Science and Technology Projects in Guangzhou
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. 2022.
2. Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, et al. Chlamydia, Gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–P562.
3. Lin XX, Meng SY, Ke WJ, Zhang XH, Wang LY, Liao YY, Liu H, Zhao PZ, Liang CM, Chen HR, et al. Community engagement on-site rapid test for chlamydia and gonorrhea among men who have sex with men: a pioneering study in Guangzhou, China. BMC Public Health. 2022;22(1):1036.
4. Zhou Y, Cai YM, Li SL, Cao NX, Zhu XF, Wang F, Han Y, Yin YP, Chen XS. Anatomical site prevalence and genotypes of chlamydia trachomatis infections among men who have sex with men: a multi-site study in China. BMC Infect Dis. 2019;19(1):1041.
5. Zhang X, Jia M, Chen M, Luo H, Chen H, Luo W, Zhang W, Ma Y, Yang C, Yang Y, et al. Prevalence and the associated risk factors of HIV, STIs and HBV among men who have sex with men in Kunming, China. Int J STD AIDS. 2017;28(11):1115–23.